Editas: 2Q Earnings Snapshot

August 6, 2018

CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Monday reported a loss of $38.7 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 82 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.

The genome editing company posted revenue of $7.4 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $6.2 million.

Editas shares have dropped slightly more than 5 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $29.09, a rise of 71 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT

Update hourly